These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27653416)

  • 1. Response to Open Peer Commentaries on "Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework".
    Evitt NH; Mascharak S; Altman RB
    Am J Bioeth; 2016 Oct; 16(10):W1-2. PubMed ID: 27653416
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework.
    Evitt NH; Mascharak S; Altman RB
    Am J Bioeth; 2015; 15(12):25-9. PubMed ID: 26632357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas systems for genome engineering and investigation.
    Concordet JP; Giovannangeli C
    Methods; 2017 May; 121-122():1-2. PubMed ID: 28645537
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
    Zaidi SS; Mahfouz MM; Mansoor S
    Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GENETIC ENGINEERING. Germline editing dominates DNA summit.
    Travis J
    Science; 2015 Dec; 350(6266):1299-300. PubMed ID: 26659031
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The New Genetic Frontier: CRISPR-Cas9?
    Hansen K
    S D Med; 2017 Jun; 70(6):245. PubMed ID: 28813758
    [No Abstract]   [Full Text] [Related]  

  • 12. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will CRISPR Germline Engineering Close the Door to an Open Future?
    Mintz RL; Loike JD; Fischbach RL
    Sci Eng Ethics; 2019 Oct; 25(5):1409-1423. PubMed ID: 30357560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology. Breaking Mendelian inheritance with CRISPR-Cas.
    Lau E
    Nat Rev Genet; 2015 May; 16(5):258-9. PubMed ID: 25869790
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial CRISPR: accomplishments and prospects.
    Peters JM; Silvis MR; Zhao D; Hawkins JS; Gross CA; Qi LS
    Curr Opin Microbiol; 2015 Oct; 27():121-6. PubMed ID: 26363124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.